Plac1 is a tumor‐specific antigen capable of eliciting spontaneous antibody responses in human cancer patients
Open Access
- 25 February 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 122 (9) , 2038-2043
Abstract
Immunoselection and tumor evasion constitutes one of the major obstacles in cancer immunotherapy. A potential solution to this problem is the development of polyvalent vaccines, and the identification of more tumor‐specific antigens is a prerequisite for the development of cancer vaccines. To identify novel tumor‐specific antigens, suppression subtractive hybridization (SSH) was performed to isolate genes differentially expressed in human hepatocellular cancer (HCC) tissues. PLAC1 (PLACenta‐specific 1) was one of the genes identified highly expressed in HCC tissues but not in paired noncancerous tissues. Further analyses revealed its expression in several other types of cancer tissues as well as tumor cell lines, but not in normal tissues except for placenta. Among HCC samples tested, 32% (22/69) showed PLAC1 mRNA expression while the protein was detected in 23.3% (7/30). A serological survey revealed that 3.8% (4/101) of HCC patients had anti‐PLAC1 antibody response, suggesting the immunogenicity of PLAC1 in HCC patients. PLAC1 represents a new class of tumor associated antigen with restricted expression in placenta and cancer tissues, that may serve as a target for cancer vaccination.Keywords
This publication has 26 references indexed in Scilit:
- Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patientsProceedings of the National Academy of Sciences, 2006
- Cancer/testis antigens, gametogenesis and cancerNature Reviews Cancer, 2005
- PLAC1 expression increases during trophoblast differentiation: Evidence for regulatory interactions with the fibroblast growth factor‐7 (FGF‐7) axisMolecular Reproduction and Development, 2005
- Therapy Insight: potential of statins for cancer chemoprevention and therapyNature Clinical Practice Oncology, 2005
- Lower Maternal PLAC1 mRNA in Pregnancies Complicated with Vaginal Bleeding (Threatened Abortion <20 Weeks) and a Surviving FetusClinical Chemistry, 2005
- Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization methodInternational Journal of Cancer, 2004
- PLAC1, a trophoblast‐specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factorMolecular Reproduction and Development, 2002
- Hepatocellular Carcinoma: An UpdateUltrastructural Pathology, 2001
- PLAC1, an Xq26 Gene with Placenta-Specific ExpressionGenomics, 2000
- CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysisInternational Journal of Cancer, 2000